Procalcitonin and Risk Prediction for Diagnosing Bacteremia in Hospitalized Patients: A Retrospective, National Observational Study
Bacteremia is associated with significant morbidity and mortality. Timely, appropriate therapy may improve clinical outcomes, and therefore, determining which patients benefit from more comprehensive diagnostic strategies (i.e., direct specimen testing) could be of value. We performed an assessment...
Main Authors: | Tristan T. Timbrook, Cherilyn D. Garner, Kyle D. Hueth, Gerald A. Capraro, Louise Zimmer, Hari P. Dwivedi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/20/3174 |
Similar Items
-
Can procalcitonin be a diagnostic marker for catheter‐related blood stream infection in children?
by: Yasemin Ozsurekci, et al.
Published: (2016-07-01) -
Mining of a Clinical Database: The Interpretation of Intense Serial Procalcitonin in the Prediction for Bloodstream Infection
by: Zhiyi Jiang, et al.
Published: (2021-10-01) -
Procalcitonin levels in candidemia versus bacteremia: a systematic review
by: Andrea Cortegiani, et al.
Published: (2019-05-01) -
A study of the effectiveness of using the serum procalcitonin level as a predictive test for bacteremia in acute pyelonephritis
by: Ga Hee Lee, et al.
Published: (2018-12-01) -
Optimal use of procalcitonin to rule out bacteremia in patients with possible viral infections
by: Kaoutar Azijli, et al.
Published: (2022-06-01)